Alexandria Real Estate Equities
Open
$41.10
Prev. Close
$41.00
High
$41.10
Low
$41.02
Market Snapshot
$7.11B
-6.7
1.80
$3.12B
514
Alexandria Real Estate Equities, Inc. engages in the provision of space for lease. The company is headquartered in Pasadena, California and currently employs 514 full-time employees. The firm is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. The company has a Labspace asset base predominantly concentrated in markets with barriers to entry.
Alexandria Real Estate Equities recorded Q1 2026 funds from operations of $636.9 million and earnings per share of $2.10, highlighting revenue stability amid fluctuations.
Alexandria Real Estate Equities, Inc. engages in the provision of space for lease. The company is headquartered in Pasadena, California and currently employs 514 full-time employees. The firm is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. The company has a Labspace asset base predominantly concentrated in markets with barriers to entry.
Recently from Cashu
Alexandria Real Estate Equities Positions for Growth in Life Sciences Real Estate Market
Strengthening Growth Dynamics in Life Sciences Real Estate Alexandria Real Estate Equities, a leading player in the life sciences real estate market, stands poised to capitalize on the rising demand f…
Alexandria Real Estate Equities: Strategic Growth in Life Sciences Amid Economic Challenges
Alexandria Real Estate Equities: Navigating the Landscape of Life Science Investments In the current climate of economic fluctuations and evolving market demands, Alexandria Real Estate Equities (ARE)…
Alexandria Real Estate Equities Declares Steady Dividend Amid Life Sciences Sector Growth
Alexandria Real Estate Equities Maintains Strong Dividend Commitment Amid Industry Growth Alexandria Real Estate Equities, Inc. (NYSE: ARE) showcases its financial stability by declaring a quarterly c…
Alexandria Real Estate Equities Declares Dividend, Signaling Financial Stability and Growth Potential
Alexandria Real Estate Equities Declares Consistent Dividend, Reinforces Financial Stability Alexandria Real Estate Equities, Inc. (NYSE: ARE), a prominent player in the life science real estate inves…